Enteric Coating Enhances the Biopharmaceutical Performance of a Silica–Lipid Formulation of Abiraterone Acetate

Ali Taheri, Ruba Almasri, Anthony Wignall, Felicia Feltrin, Kristen E. Bremmell, Paul Joyce, Clive A. Prestidge

Open source

DOI
10.3390/pharmaceutics17101289
Published
2025-10-02
Container
Pharmaceutics
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/pharmaceutics17101289,
  title = {Enteric Coating Enhances the Biopharmaceutical Performance of a Silica–Lipid Formulation of Abiraterone Acetate},
  author = {Ali Taheri and Ruba Almasri and Anthony Wignall and Felicia Feltrin and Kristen E. Bremmell and Paul Joyce and Clive A. Prestidge},
  year = {2025},
  journal = {Pharmaceutics},
  doi = {10.3390/pharmaceutics17101289},
  url = {https://doi.org/10.3390/pharmaceutics17101289}
}

RIS

TY  - JOUR
TI  - Enteric Coating Enhances the Biopharmaceutical Performance of a Silica–Lipid Formulation of Abiraterone Acetate
AU  - Ali Taheri
AU  - Ruba Almasri
AU  - Anthony Wignall
AU  - Felicia Feltrin
AU  - Kristen E. Bremmell
AU  - Paul Joyce
AU  - Clive A. Prestidge
PY  - 2025
JO  - Pharmaceutics
DO  - 10.3390/pharmaceutics17101289
UR  - https://doi.org/10.3390/pharmaceutics17101289
ER  - 

APA

Taheri, A., Almasri, R., Wignall, A., Feltrin, F., Bremmell, K. E., Joyce, P., & Prestidge, C. A. (2025). Enteric Coating Enhances the Biopharmaceutical Performance of a Silica–Lipid Formulation of Abiraterone Acetate. Pharmaceutics. https://doi.org/10.3390/pharmaceutics17101289

Source records